Gordon Ritchie

Dr. Gordon Ritchie


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NMNancy Matic
Nancy Matic
ASAleksandra Stefanovic
Aleksandra Stefanovic
Victor C. M. LeungVictor C. M. Leung
Victor C. M. Leung
TLTanya Lawson
Tanya Lawson
GRGordon Ritchie
Gordon Ritchie
CLChristopher Lowe
Christopher Lowe
Due to global shortages of flocked nasopharyngeal swabs and appropriate viral transport media during the COVID-19 pandemic, alternate diagnostic specimens for SARS-CoV-2 detection are sought. The accuracy and feasibility of saliva samples collected and transported without specialized collection devices or media were evaluated. Saliva demonstrated good concordance with paired nasopharyngeal swabs for SARS-CoV-2 detection in 67/74 cases (90.5%), though barriers to saliva collection were observed in long-term care residents and outbreak settings. SARS-CoV-2 RNA was stable in human saliva at room temperature for up to 48 hours after initial specimen collection, informing appropriate transport time and conditions.

8 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NKNatalie Kinloch
Natalie Kinloch
GRGordon Ritchie
Gordon Ritchie
CBChanson J Brumme
Chanson J Brumme
WDWinnie Dong
Winnie Dong
WDWeiyan Dong
Weiyan Dong
ZBZabrina L Brumme
Zabrina L Brumme
Improper nasopharyngeal swab collection could contribute to false-negative COVID-19 results. In support of this, specimens from confirmed or suspected COVID-19 cases that tested negative or indeterminate ( i.e. suspected false-negatives) contained less human DNA (a stable molecular marker of sampling quality) compared to a representative pool of specimens submitted for testing.

Verified
Journal Article
Open access
PDF file
Victor C. M. LeungVictor C. M. Leung
Victor C. M. Leung
GRGordon Ritchie
Gordon Ritchie
ASAleksandra Stefanovic
Aleksandra Stefanovic
Colin LeeColin Lee
Colin Lee
SCSamuel Chorlton
Samuel Chorlton
CLChristopher Lowe
Christopher Lowe
Background: We describe a community-based outbreak of multidrug-resistant Shigella flexneri serotype 2a among people experiencing homelessness (PEH) in Vancouver’s Downtown Eastside during the COVID-19 pandemic. Methods: In this observational cohort study, we followed the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) reporting guidelines. We identified cases by laboratory surveillance and collected demographic and clinical data from the medical charts or patient interviews. We implemented enhanced surveillance and disseminated testing and management guidelines. Shigella flexneri isolates were serotyped, and whole-genome sequencing was performed. Results: We identified 101 confirmed cases of Shigella flexneri 2a (80% male; median age 43) between 31 January and 16 December 2021. All the affected individuals experienced homelessness, and substance use disorder was the most common comorbidity (88%). Five patients required ICU hospitalization, and one death occurred within 30 days. Core-genome multilocus sequence typing analysis confirmed a clonal outbreak. All S. flexneri isolates were phenotypically and genotypically multidrug-resistant. Conclusions: COVID-19 exacerbated longstanding public health concerns around the dearth of hygiene and sanitation resources available to PEH. Preventing similar outbreaks will require addressing these risks and finding solutions to the crisis of homelessness in Canada.

1 January 2021 in Hepatology Forum
Verified
Journal Article
Open access
PDF file
HBHarjot K. Bedi
Harjot K. Bedi
RTRoberto Trasolini
Roberto Trasolini
CLChristopher F. Lowe
Christopher F. Lowe
THTrana Hussaini
Trana Hussaini
MBMark Bigham
Mark Bigham
EYEric M. Yoshida
Eric M. Yoshida
Liver transplant donors and recipients are routinely screened for hepatitis B virus (HBV) infection by measuring the levels of hepatitis B surface antigen (HBsAg) and hepatitis B core (anti-HBc) antibodies. Organs are accepted from donors who are HB-negative, and increased monitoring is required for organs from donors considered at increased risk. Transplant recipients are vaccinated if there is no sign of previous infection or immunity and monitored for reactivation in case of previous HBV infection. In cases where both the donor and the recipient are HBV-negative, no antiviral prophylaxis is used post transplant. This report describes a case of an HBV-immunized, anti-HBc-negative patient who underwent an orthotopic liver transplant from an anti-HBc-negative donor. The patient did not receive post-transplant antiviral prophylaxis due to mutual anti-HBc-seronegative status. However, the recipient developed HBV infection with isolated HBsAg and persistently negative anti-HBc. Mutations in the core/pre-core regions of the HBV gene were not implicated for unique serology in this case. Immunosuppression post liver transplant is the likely etiology for isolated HBsAg seroconversion despite significantly elevated HBV DNA. Our experience suggests that HBV DNA screening of liver transplant donors and recipients, in addition to HBV DNA monitoring of recipients, may reduce the risk of transplant-associated HBV.

14 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NMNancy Matic
Nancy Matic
TLTanya Lawson
Tanya Lawson
GRGordon Ritchie
Gordon Ritchie
ASAleksandra Stefanovic
Aleksandra Stefanovic
Victor C. M. LeungVictor C. M. Leung
Victor C. M. Leung
CLChristopher Lowe
Christopher Lowe
With surging global demand for increased SARS-CoV-2 testing capacity, clinical laboratories seek automated, high-throughput molecular solutions, particularly for specimen types which do not rely upon supply of specialized collection devices or viral transport media (VTM). Saliva was evaluated as a diagnostic specimen for SARS-CoV-2 using the cobas® SARS-CoV-2 Test on the cobas® 6800 instrument. Saliva specimens submitted from various patient populations under investigation for COVID-19 from March-July 2020 were processed in the laboratory with sterile phosphate-buffered saline in a 1:2 dilution and vortexed with glass beads. The processed saliva samples were tested using a commercial assay for detection of the SARS-CoV-2 E gene (LightMix®) in comparison to the cobas® SARS-CoV-2 Test. 22/64 (34.4%) of the saliva samples were positive for SARS-CoV-2. Positive and negative concordance between the LightMix® and cobas® assays were 100%. There was no cross-contamination of samples observed on the cobas® 6800. The overall invalid rate for saliva on the cobas® 6800 (1/128, 0.78%) was similar to the baseline invalid rate observed for nasopharyngeal swabs/VTM and plasma samples. Saliva is a feasible specimen type for SARS-CoV-2 testing on the cobas® 6800, with potential to improve turnaround time and enhance testing capacity.

25 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NKNatalie Kinloch
Natalie Kinloch
ASAniqa Shahid
Aniqa Shahid
GRGordon Ritchie
Gordon Ritchie
WDWinnie Dong
Winnie Dong
TLTanya Lawson
Tanya Lawson
Victor C. M. LeungVictor C. M. Leung
Victor C. M. Leung
Nasopharyngeal swabs are critical to the diagnosis of respiratory infections including COVID-19, but collection techniques vary. We compared two recommended nasopharyngeal swab collection techniques in adult volunteers and found that swab rotation following nasopharyngeal contact did not recover additional nucleic acid (as measured by human DNA/RNA copy number). Rotation was also less tolerable for participants. Notably, both discomfort and nucleic acid recovery were significantly higher in Asians, consistent with nasal anatomy differences. Our results suggest that it is unnecessary to rotate the swab in place following contact with the nasopharynx, and reveal that procedural discomfort levels can differ by ethnicity. summary: Nasopharyngeal swabs are critical to COVID-19 diagnostics, but collection techniques vary. Comparison of two collection techniques revealed that swab rotation did not recover more nucleic acid and was more uncomfortable. Discomfort and biological material recovery also varied by participant ethnicity.